MedTrace Logo

Dose Proportionality of Fexofenadine in Healthy Human Egyptian Volunteers

NCT01767272 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2013-01-14

No results posted yet for this study

Summary

The present study was adopted to evaluate the pharmacokinetics and dose linearity of fexofenadine after oral administration.

Conditions

  • Healthy

Interventions

DRUG

fexofenadine

fexofenadine brand name

Sponsors & Collaborators

  • Damanhour University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-12-31
Primary Completion
2013-01-31
Completion
2013-01-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01767272 on ClinicalTrials.gov